Anika Therapeutics (ANIK) Other Working Capital Changes (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Other Working Capital Changes data on file, last reported at $1.7 million in Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 33.18% year-over-year to -$574000.0 in Q4 2023; TTM through Dec 2023 was -$1.8 million, a 128.32% decrease from a year earlier, with the FY2024 full-year figure at -$2.1 million, up 3.12% from the prior year.
• Other Working Capital Changes for Q4 2023 stood at -$574000.0, down from -$527000.0 in the prior quarter.
• Over the last five years, Other Working Capital Changes for ANIK reached as high as -$290000.0 in Q3 2022 and fell as low as -$574000.0 in Q4 2023.
• Historically, Other Working Capital Changes has averaged -$54411.8 across 5 years, with a median of -$54000.0 in 2024.
• Across the five-year window, Other Working Capital Changes soared 1466.67% in 2022 and slumped 2327.78% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at -$431000.0 in 2022, then plunged by 33.18% to -$574000.0 in 2023.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$574000.0 in Q4 2023, -$527000.0 in Q3 2023, and -$431000.0 in Q4 2022.